Stocks-SNDX-Syndax Pharmaceuticals Inc

SNDX Syndax Pharmaceuticals Inc

27.96 -0.59 (-2.07%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest
-2.17% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
1.9B
Day’s Range
27.88
-
28.97
52W Range
13.30
-
29.73
Volume (3M)
866.33K
Price-Earnings Ratio
5.18K
Revenue
126.58M

Syndax Pharmaceuticals Inc Latest News

View All
Pinned Post
eToro Team
🎉 Here’s a little preview introducing 16 YEARS of INVESTING on eToro 😏🤑 With love, - The eToro Team youtu.be/UFYvpJxh2qA
Like CommentShare
Show more comments2 of 63
null
.
Top Discussions
Carlos Enrique Figueroa Vaca
Edited
Stock futures gained Friday, suggesting indexes could end the week on a stronger footing after concerns about a slowing economy drove markets lower in recent days. Futures for the S&P 500 index ticked up 0.3%, after the benchmark logged three days of declines. Futures for the tech-heavy Nasdaq-100 gained... Show More
Like CommentShare
null
.
Carlos Enrique Figueroa Vaca
U.S. stock futures fell Thursday, while the dollar advanced and bond yields rose, as strong labor-market data bolstered the case for the Federal Reserve to remain tough. Futures tied to the S&P 500 fell 0.5%. Dow Jones Industrial Average futures and Nasdaq-100 futures declined 0.6% and 0.5%, respectively.... Show More
Like CommentShare
3 replies
null
.
Carlos Enrique Figueroa Vaca
𝟯𝟮.𝟬𝟬% in 2021, and 𝟭.𝟴𝟭% since the start of 2022. U.S. stock futures were little changed ahead of the Federal Reserve’s final interest-rate decision of the year. Futures tied to the S&P 500 fell 0.1% while contracts on the tech-heavy Nasdaq-100 lost 0.2%. Futures for the Dow Jones Industrial... Show More
Like CommentShare
1 reply
null
.
MarketUpdates
Edited
$SNDX (Syndax Pharmaceuticals Inc) Q4 2022 earnings report is expected to be released
27
FEB
REPORTS
Syndax Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open
Notify me
SNDX
SNDX
Syndax Pharmaceuticals Inc
27.96
-0.59
(-2.07%)
Trade
SNDX
Syndax Pharmaceuticals Inc
27.90
-0.59 (-2.07%)
Trade
MarketUpdates
$SNDX (Syndax Pharmaceuticals Inc) Q4 2022 earnings report is expected to be released

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company that operates internationally. It works to develop therapies to treat cancer. Founded in 2005, the company has headquarters in Waltham, Massachusetts. Syndax Pharmaceuticals is listed on the NASDAQ GS stock market under the tickerSNDX. Follow SNDX share price movements with the help of your eToro watchlist.
59
Employees
Waltham, Massachusetts, US
HQ
2005
Founded
Michael A. Metzger, MBA
CEO
Show More

Upcoming Earnings

27
FEB
REPORTS
Syndax Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
48
Low
Industry 
Avg. 45 
32
Environment
45
Social
59
Governance

People Also Bought